1. Generics Bulletin
  2. >>Business
  3. >>Deals

Zentiva Buys Sanofi's Ankleshwar Site

 
• By Anju Ghangurde and Dave Wallace

Zentiva has struck a deal to acquire a manufacturing site in Ankleshwar, India, from its former parent company Sanofi.

Trees
Zentiva has acquired the site from its former parent • Source: Shutterstock

Zentiva has struck a deal with its former parent company, Sanofi to acquire a manufacturing site in Ankleshwar, India, for about INR2.61bn ($36.5m). The generics firm said the acquisition would give it a boost by “expanding the footprint and agility of Zentiva’s manufacturing network.”

Nick Haggar, CEO of Zentiva, said that expanding the firm's network of wholly-owned manufacturing sites was “a key factor in our future success, ensuring greater security of supply for people living in Europe and beyond

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Sandoz Slims Down Pembrolizumab Trial As Regulators Streamline Requirements

 
• By Dave Wallace

As Sandoz continues development of its planned pembrolizumab biosimilar rival to Keytruda, the company has revealed plans to slim down its Phase III trial amid the latest moves from regulators towards streamlining clinical study requirements for biosimilar registration.

Amgen’s Aflibercept Starts Strong As Regeneron Counts Cost Of Eylea Competition

 
• By Dean Rudge

Amgen told investors during its 1 May first-quarter earnings call that its Pavblu biosimilar to Eylea 2mg had flown out of the gates, while Regeneron admitted “some difficult news related to our retinal franchise.”

BGMA Becomes Medicines UK

 
• By Dave Wallace

The UK generics and biosimilars industry will now be represented by Medicines UK, the new name for the former British Generic Manufacturers Association.